衞寧健康(300253.SZ):實控人及一致行動人之間內部轉讓計劃完成
格隆匯 7 月 24日丨衞寧健康(300253.SZ)公佈,2020年7月24日,公司收到控股股東、實際控制人周煒、王英及一致行動人周成出具的《計劃完成的告知函》,周煒、王英於2020年7月15日至2020年7月24日期間通過大宗交易方式共轉讓3491.9萬股(佔公司總股本的1.64%)給周成為唯一所有人的六個私募基金產品,同時周煒、王英、周成與該六個私募基金產品簽署一致行動協議。
此次交易屬於公司控股股東、實際控制人及一致行動人成員或構成發生變化,其合計持股比例和數量未發生變化,不涉及向市場減持,不會導致公司控股股東、實際控制人的變化,不會影響公司治理結構和持續經營。
此次增加一致行動人及持股在一致行動人之間內部轉讓事項與此前已披露的計劃一致,此次計劃已實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.